Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation.
Halamoda-Kenzaoui B, Vandebriel RJ, Howarth A, Siccardi M, David CAW, Liptrott NJ, Santin M, Borgos SE, Bremer-Hoffmann S, Caputo F. Halamoda-Kenzaoui B, et al. Among authors: vandebriel rj. J Control Release. 2021 Aug 10;336:192-206. doi: 10.1016/j.jconrel.2021.06.016. Epub 2021 Jun 12. J Control Release. 2021. PMID: 34126169 Free PMC article. Review.
An inter-laboratory effort to harmonize the cell-delivered in vitro dose of aerosolized materials.
Bannuscher A, Schmid O, Drasler B, Rohrbasser A, Braakhuis HM, Meldrum K, Zwart EP, Gremmer ER, Birk B, Rissel M, Landsiedel R, Moschini E, Evans SJ, Kumar P, Orak S, Doryab A, Erdem JS, Serchi T, Vandebriel RJ, Cassee FR, Doak SH, Petri-Fink A, Zienolddiny S, Clift MJD, Rothen-Rutishauser B. Bannuscher A, et al. Among authors: vandebriel rj. NanoImpact. 2022 Oct;28:100439. doi: 10.1016/j.impact.2022.100439. Epub 2022 Nov 17. NanoImpact. 2022. PMID: 36402283 Free article.
A comparative biodistribution study of polymeric and lipid-based nanoparticles.
Åslund AKO, Vandebriel RJ, Caputo F, de Jong WH, Delmaar C, Hyldbakk A, Rustique E, Schmid R, Snipstad S, Texier I, Vernstad K, Borgos SEF. Åslund AKO, et al. Among authors: vandebriel rj. Drug Deliv Transl Res. 2022 Sep;12(9):2114-2131. doi: 10.1007/s13346-022-01157-y. Epub 2022 Apr 15. Drug Deliv Transl Res. 2022. PMID: 35426570 Free PMC article.
Standardization of an in vitro assay matrix to assess cytotoxicity of organic nanocarriers: a pilot interlaboratory comparison.
Eder KM, Marzi A, Wågbø AM, Vermeulen JP, de la Fonteyne-Blankestijn LJJ, Rösslein M, Ossig R, Klinkenberg G, Vandebriel RJ, Schnekenburger J. Eder KM, et al. Among authors: vandebriel rj. Drug Deliv Transl Res. 2022 Sep;12(9):2187-2206. doi: 10.1007/s13346-022-01203-9. Epub 2022 Jul 6. Drug Deliv Transl Res. 2022. PMID: 35794354 Free PMC article.
Nanomedicinal products: a survey on specific toxicity and side effects.
Brand W, Noorlander CW, Giannakou C, De Jong WH, Kooi MW, Park MV, Vandebriel RJ, Bosselaers IE, Scholl JH, Geertsma RE. Brand W, et al. Among authors: vandebriel rj. Int J Nanomedicine. 2017 Aug 22;12:6107-6129. doi: 10.2147/IJN.S139687. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28883724 Free PMC article.
127 results